is a metabolic switch that shifts hepatic energy storage from lipid to glycogen.

The gene, encoding PPP1R3B protein, is critical for liver glycogen synthesis and maintaining blood glucose levels. Genetic variants affecting expression are associated with several metabolic traits and liver disease, but the precise mechanisms are not fully understood. We studied the effects of both overexpression and deletion in mice and cell models and found that both changes in expression result in dysregulated metabolism and liver damage, with overexpression increasing liver glycogen stores, while deletion resulted in higher liver lipid accumulation. These patterns were confirmed in humans where variants increasing expression had lower liver fat and decreased plasma lipids, whereas putative loss-of-function variants were associated with increased liver fat and elevated plasma lipids. These findings support that PPP1R3B is a crucial regulator of hepatic metabolism beyond glycogen synthesis and that genetic variants affecting expression levels influence if hepatic energy is stored as glycogen or triglycerides.